Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease
Manoj K Rathinaswamy, John E. Burke
Advances in Biological Regulation (2019) Vol. 75, pp. 100657-100657
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
Karen Griselda de la Cruz-López, Mariel Esperanza Toledo Guzmán, Elizabeth Sánchez, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 178
Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways
Manuel Humberto Cháirez‐Ramírez, Karen Griselda de la Cruz-López, Alejandro Garcı́a-Carrancá
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 142
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
Shanshan Zhou, Zhongzhu Ai, Weinan Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 72
Inflammation: A New Look at an Old Problem
Evgeni Gusev, Yulia A. Zhuravleva
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4596-4596
Open Access | Times Cited: 65
The role of PI3Kγ in the immune system: new insights and translational implications
Stephen M. Lanahan, Matthias P. Wymann, C. Lucas
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 687-700
Open Access | Times Cited: 56
The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity
Ariel Tsay, Jen-Chywan Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12665-12665
Open Access | Times Cited: 34
Regulators involved in trophoblast syncytialization in the placenta of intrauterine growth restriction
Hanjing Zhou, Chenqiong Zhao, Peixin Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
Minni Zhang, Kun Liu, Qiuyue Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 15
Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives
Seyed Mohsen Aghaei Zarch
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 486-507
Open Access | Times Cited: 12
Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions
Hongyao Li, Xiang Wen, Yueting Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression
Alireza Mafi, Seyedeh Mahdieh Khoshnazar, Amirhossein Shahpar, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155442-155442
Closed Access | Times Cited: 11
Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer
Iseult Browne, Alicia Okines
Cancers (2024) Vol. 16, Iss. 12, pp. 2259-2259
Open Access | Times Cited: 8
Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress
Yi Duan, Johannes Haybaeck, Zhihui Yang
Cancers (2020) Vol. 12, Iss. 10, pp. 2972-2972
Open Access | Times Cited: 67
Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy
Elaheh Amirani, Jamal Hallajzadeh, Zatollah Asemi, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 456-467
Closed Access | Times Cited: 51
Molecular basis for differential activation of p101 and p84 complexes of PI3Kγ by Ras and GPCRs
Manoj K Rathinaswamy, Meredith L. Jenkins, Benjamin R. Duewell, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112172-112172
Open Access | Times Cited: 21
Exosomal miR‐21‐5p derived from bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion by targeting PIK3R1
Jin Qi, Ruihao Zhang, Yapeng Wang
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 23, pp. 11016-11030
Open Access | Times Cited: 37
Chemical Constituents and Hypoglycemic Mechanisms of Dendrobium nobile in Treatment of Type 2 Diabetic Rats by UPLC-ESI-Q-Orbitrap, Network Pharmacology and In Vivo Experimental Verification
Zhaoyang Li, Meiling Zeng, Keyong Geng, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2683-2683
Open Access | Times Cited: 15
ATP-competitive and allosteric inhibitors induce differential conformational changes at the autoinhibitory interface of Akt1
Alexandria L. Shaw, Matthew AH Parson, Linda Truebestein, et al.
Structure (2023) Vol. 31, Iss. 3, pp. 343-354.e3
Open Access | Times Cited: 13
Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF–MS/MS and network pharmacology
Xiaona Lu, Yawei Zheng, Fang Wen, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes
Vyanka Redenbaugh, Tanya Coulter
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 27
PI3K and AKT at the Interface of Signaling and Metabolism
Giovanni Solinas, Barbara Becattini
Current topics in microbiology and immunology (2022), pp. 311-336
Closed Access | Times Cited: 20
Cryo-EM structures reveal two allosteric inhibition modes of PI3KαH1047R involving a re-shaping of the activation loop
Xiuliang Huang, Kailiang Wang, Jing Han, et al.
Structure (2024) Vol. 32, Iss. 7, pp. 907-917.e7
Closed Access | Times Cited: 4
A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism
Narendra Thapa, Mo Chen, Vincent L. Cryns, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114119-114119
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top